Search for Clinical Trial Results
Nasal Polyps - 33 Studies Found
Status | Study |
Completed |
Study Name: Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia Condition: Chronic Sinusitis With Nasal Polyps and Eosinophilia Date: 2014-08-12 Interventions: Drug: dexpramipexole Dexpramipexole capsule-shaped film-coated tablets at the dose strength of 150 mg ad |
Recruiting |
Study Name: Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps Condition:
Date: 2017-02-14 Interventions: Drug: Verapamil Hydrochloride Intranasal Verapamil solution for injection, supplied in vials, will be ut |
Completed |
Study Name: Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps Condition: Chronic Sinusitis With or Without Nasal Polyps Date: 2012-06-14 Interventions: Drug: Fluticasone Propionate Fluticasone Propionate 400 μg |
Completed |
Study Name: Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial Condition:
Date: 2010-09-08 Interventions:
|
Completed |
Study Name: Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis Condition:
Date: 2010-02-08 Interventions:
|
NOT_YET_RECRUITING |
Study Name: Identifying Predictors Of Response To Mepolizumab In CRSwNP Condition: Date: 2024-06-18 Interventions: Patients will receive Mepolizumab 100mg SC once every 4 weeks for 48 weeks (twelve injections, no placebo) at the hospital.The IMP will be admin |
NOT_YET_RECRUITING |
Study Name: The Role of IL5 in Epithelial Cell Integrity Condition: Date: 2024-06-18 Interventions: In vitro exposure of human nasal epithelial cells to mepolizumab |
NOT_YET_RECRUITING |
Study Name: Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps Condition: Date: 2024-06-18 Interventions: SHR-1905 Injection |
RECRUITING |
Study Name: A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps Condition: Chronic Rhinosinusitis With Nasal Polyps Date: 2024-06-18 Interventions: Verekitug (UPB-101) 0.5 mL of formulated solution (100 mg verekitug [UPB-101]) |
NOT_YET_RECRUITING |
Study Name: Early-onset Dupilumab Effects in CRSwNP Condition: Chronic Rhinosinusitis With Nasal Polyps Date: 2024-06-18 Interventions: Two injections of 300mg dupilumab, subcutaneous 14 days apart |